Emerging artemisinin resistance in the border areas of Thailand

@article{NaBangchang2013EmergingAR,
  title={Emerging artemisinin resistance in the border areas of Thailand},
  author={Kesara Na-Bangchang and Juntra Karbwang},
  journal={Expert Review of Clinical Pharmacology},
  year={2013},
  volume={6},
  pages={307 - 322}
}
Emergence of artemisinin resistance has been confirmed in Cambodia and the border areas of Thailand, the well-known hotspots of multidrug resistance Plasmodium falciparum. It appears to be spreading to the western border of Thailand along the Thai–Myanmar border, and will probably spread to other endemic areas of the world in the near future. This raises a serious concern on the long-term efficacy of artemisinin-based combination therapies, as these combination therapies currently constitute… 

Clinical impact of the two ART resistance markers, K13 gene mutations and DPC3 in Vietnam

No treatment failure has been observed in presence of high prevalence of ART resistance and in absence of PPQ resistance, and the effectiveness of malaria control strategies was very high in the studied districts.

In vivo monitoring of dihydroartemisinin-piperaquine sensitivity in Plasmodium falciparum along the China-Myanmar border of Yunnan Province, China from 2007 to 2013

DAPQ sensitivity in P. falciparum had not significantly changed along the China-Myanmar border of Yunnan Province, China and more attentions should be given to becoming slower fever and parasite clearance.

Multiple Phenotypic and Genotypic Artemisinin Sensitivity Evaluation of Malian Plasmodium falciparum Isolates.

The assays presented here appear as valuable tools for the monitoring of artemisinin sensitivity in the field and thus could help to evaluate the risk of emergence of art Artemisinin resistance in Africa.

Four years’ monitoring of in vitro sensitivity and candidate molecular markers of resistance of Plasmodium falciparum to artesunate-mefloquine combination in the Thai-Myanmar border

High prevalence of CQ and MQ-resistant P. falciparum isolates was observed during the four-year observation period (2006–2009), and AS sensitivity was declined, while QN sensitivity was improved.

Malaria Elimination in the People’s Republic of China: Current Progress, Challenges, and Prospects

This chapter is meant to share the lessons learned from malaria elimination in China benefiting countries on the way to malaria elimination.

Population pharmacokinetic properties of artemisinin in healthy male Vietnamese volunteers

This is the first population pharmacokinetic characterization of artemisinin in healthy volunteers and the traditional bioequivalence evaluation were comparable with results obtained from mixed-effects modelling.

Malaria , Sporozoites , Invasion , Molecular targets , Vaccines

Current knowledge in this field is reviewed with the aim of highlighting opportunities available for effective malaria interventions.

Polymorphisms in Plasmodium falciparum Kelch 13 and P. vivax Kelch 12 Genes in Parasites Collected from Three South Pacific Countries Prior to Extensive Exposure to Artemisinin Combination Therapies

Four Kelch 13 and two Kelch 12 novel sequence polymorphisms, not associated with artemisinin resistance, were observed in parasites from Solomon Islands and Vanuatu and no polymorphism was observed in PNG parasites.

Altering Antimalarial Drug Regimens May Dramatically Enhance and Restore Drug Effectiveness

It is argued that twice-daily dosing should be incorporated into all ACT regimen design considerations as a simple and effective way of ensuring the continued long-term effectiveness of ACTs.

References

SHOWING 1-10 OF 149 REFERENCES

Evidence of artemisinin-resistant malaria in western Cambodia.

Artemisinins are potent and rapidly acting antimalarial drugs, and their widespread use for treating patients with Plasmodium falciparum malaria raises the question of emerging drug resistance.

Drug resistant malaria on the Thai-Myanmar and Thai-Cambodian borders.

The introduction of artesunate-mefloquine combination in selected areas along the two borders in 1995 is believed to be one of the multiple factors responsible for stabilizing the multidrug resistance problems in Thailand today.

Artemisinin resistance in Cambodia: a clinical trial designed to address an emerging problem in Southeast Asia.

  • H. NoedlYoury Se Lon Chan Thap
  • Medicine, Biology
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2010
Artemisinin resistance has emerged along the Thai-Cambodian border and the potentially devastating implications of spreading resistance to a drug that currently has no successor call for further studies of this emerging problem.

Molecular monitoring of Plasmodium falciparum resistance to artemisinin in Tanzania

Resistance to artemisinin has not yet been selected in Tanzania, supporting the Ministry of Health's decision to adopt artemether+lumefantrine as first-line malaria treatment.

The last man standing is the most resistant: eliminating artemisinin-resistant malaria in Cambodia

Containment of artemisinin-resistant malaria can be achieved by elimination of malaria from western Cambodia using ACT, and the "last man standing" is the most resistant and thus this strategy must be sustained until elimination is truly achieved.

Artemisinin resistance containment project in Thailand. II: responses to mefloquine-artesunate combination therapy among falciparum malaria patients in provinces bordering Cambodia

Anti-malarial drug-resistant parasites should be closely monitored in the area along the Thai-Cambodian border, although the MAS cure rate in this study area was above 90%, an increasing trend of treatment failure has been reported in neighboring parts.

A major transition in malaria treatment: the adoption and deployment of artemisinin-based combination therapies.

After a period of market instability, the global manufacturing capacity for ACTs is now sufficient to meet the demand, however, increased and sustained financing will be necessary to extend the current levels of ACT coverage.

Discovery, mechanisms of action and combination therapy of artemisinin

  • L. CuiX. Su
  • Medicine, Biology
    Expert review of anti-infective therapy
  • 2009
The history of artemisinin discovery is reviewed, the mode of action and potential drug targets are discussed, and strategies to elucidate resistance mechanisms are presented.
...